Chicago Capital, LLC Neogenomics Inc Transaction History
Chicago Capital, LLC
- $4.02 Billion
- Q2 2025
A detailed history of Chicago Capital, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Chicago Capital, LLC holds 23,392 shares of NEO stock, worth $142,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,392
Previous 24,007
2.56%
Holding current value
$142,223
Previous $227,000
25.11%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
284Shares Held
126MCall Options Held
952KPut Options Held
135K-
Black Rock Inc. New York, NY19.7MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$85.9 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$45.2 Million2.32% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$40.8 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$36.7 Million7.36% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $765M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...